DF
MRNA icon

Dunhill Financial’s Moderna MRNA Stock Holding History

Dunhill Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Sell
16
-2
-11% -$103 ﹤0.01% 987
2026
Q1 		$949 Hold
18
– – ﹤0.01% 978
2025
Q4 		$535 Buy
18
+10
+125% +$272 ﹤0.01% 925
2025
Q3 		$210 Sell
8
-5
-38% -$139 ﹤0.01% 925
2025
Q2 		$367 Sell
13
-10
-43% -$263 ﹤0.01% 891
2025
Q1 		$657 Buy
23
+6
+35% +$213 ﹤0.01% 823
2024
Q4 		$712 Sell
17
-46
-73% -$2.2K ﹤0.01% 769
2024
Q3 		$4.24K Buy
63
+26
+70% +$2.39K ﹤0.01% 590
2024
Q2 		$4.35K Buy
37
+5
+16% +$633 ﹤0.01% 414
2024
Q1 		$3.36K Buy
32
+5
+19% +$504 ﹤0.01% 390
2023
Q4 		$2.64K Buy
+27
New +$2.27K ﹤0.01% 396

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Dunhill Financial's MRNA Position: Q2 2026 in Review

Dunhill Financial reduced its Moderna (MRNA) stake by 11% in Q2 2026, selling an estimated $103 and leaving 16 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Dunhill Financial first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.35K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Dunhill Financial held 16 shares of Moderna worth $1.14K as of Q2 2026.
  • Dunhill Financial sold 2 Moderna shares in Q2 2026, an estimated $103.
  • Moderna made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #987 holding.
  • Dunhill Financial first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Moderna position peaked at $4.35K in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.